Negative pressure wound therapy after mastectomy
Official title: Is Negative Pressure Wound Therapy Associated With a Decreased Risk of Postoperative Seroma in Breast Cancer Patients Who Have Undergone Mastectomy?
Run by Dalarna County Council, Sweden · NCT07607366 · Data updated 2026-11-12
This study tests whether a negative pressure dressing after mastectomy reduces fluid build‑up and common wound complications in women with breast cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 76 (estimated) |
| Sponsor | Dalarna County Council, Sweden Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Falun) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | March 1, 2027 |
| Study ends | September 1, 2027 |
| Registry record updated | July 31, 2026 |
| Trial ID | NCT07607366 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older undergoing mastectomy for breast cancer at Falun hospital who do not have direct implant reconstruction planned.
✕Probably not a fit
Patients who do not experience seroma risk reduction or who have factors that negate benefit from negative pressure therapy may not see an improvement.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study investigates if negative pressure wound therapy, applied after mastectomy, lowers the risk of postoperative seroma and other wound problems compared with standard dressings. The approach uses a specific negative pressure system to manage the wound bed and drainage. Eligible participants are adult women undergoing mastectomy for breast cancer at Falun hospital. The trial compares outcomes such as seroma, infection, bleeding, and wound healing between the two dressing strategies. Results could influence postoperative care practices for mastectomy patients if the therapy proves beneficial.
Why it matters
Potential benefit: If successful, patients may experience fewer postoperative seromas and related wound complications, potentially shortening recovery and improving comfort.
How similar studies have gone: There is some prior evidence suggesting negative pressure therapy may improve wound healing and reduce seroma, but results vary by setting and procedure.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Breast cancer patients undergoing mastectomy * Female * Age \>= 18 years Exclusion Criteria: * Direct reconstruction with implants * The use of Harmonic Johnson and Johnson instrument during surgery
Where it's running
-
Falu Lasarett
Falun, Sweden Recruiting
Study contacts
- Study coordinator: Rebecca Paul, Dr
- Email: rebecca.paul@regiondalarna.se
- Phone: 023-490000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oncoliq blood test for early detection of breast cancer
This project will test whether a blood-based miRNA panel (the Oncoliq Test) can detect early breast cancer in adults 40–70 by comparing newly diagnosed, untreated patients with cancer-free controls.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
ATUSA 3D automated breast ultrasound for suspicious breast lesions
This study will test whether the ATUSA 3D automated breast ultrasound system can produce high-quality images that match biopsy results in women with BI-RADS 4 or 5 breast findings.
-
Support tool for women with HR+ breast cancer on long-term endocrine therapy
This study tests a SHIELD web- and app-based portal to help women with hormone receptor–positive breast cancer manage symptoms while on long-term endocrine treatment.
-
Conformal ablative radiotherapy for older women with localized ER-positive, HER2-negative breast cancer choosing non-surgical care
This study will test whether five focused SABR treatments can control ER-positive, HER2-negative breast tumors up to 5 cm in women aged 65 and older who are opting for non-surgical management.
-
UCF MammoChat mammogram image repository for AI development
This project collects donated mammogram images and questionnaire data from adults who had breast imaging to help build and test AI that could read mammograms more accurately.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.